Advanced search
Instruments
| Name | Stock exchange | Average volume | Price | Type | ||
|---|---|---|---|---|---|---|
| HANG LUNG GROUP LIMITED | 10 | Hong Kong S.E. +4 Other | 2,533,498 |
9.06
HKD
 | Stock | |
| HANG LUNG GROUP LIMITED | HLU | Deutsche Boerse AG | - |
1.05
EUR
| ||
| HANG LUNG GROUP LIMITED | HLU | Börse Stuttgart | - |
1.05
EUR
| ||
| HANG LUNG GROUP LIMITED | HNLGF | OTC Markets | 0 |
1.18
USD
| ||
| HANG LUNG GROUP LIMITED | HLU | Berne S.E. | - | - CHF
| ||
| HANG LUNG PROPERTIES LIMITED | HLPPY | OTC Markets +1 Other | 257,160 |
5.13
USD
| Stock | |
| HANG LUNG PROPERTIES LIMITED | AOP0 | BOERSE MUENCHEN | - |
4.92
EUR
| ||
| HANG LUNG PROPERTIES LIMITED | 101 | Hong Kong S.E. +5 Other | 14,893,893 |
7.98
HKD
| Stock | |
| HANG LUNG PROPERTIES LIMITED | AOP | Deutsche Boerse AG | 107 |
0.97
EUR
| ||
| HANG LUNG PROPERTIES LIMITED | AOP | Börse Stuttgart | - |
0.93
EUR
| ||
| HANG LUNG PROPERTIES LIMITED | AOP | BOERSE MUENCHEN | 424 |
0.95
EUR
| ||
| HANG LUNG PROPERTIES LIMITED | HLPPF | OTC Markets | 198,657 |
1.02
USD
| ||
| HANG LUNG PROPERTIES LIMITED | AOP | Berne S.E. | - | - CHF
| ||
| HANG LUNG GROUP LIMITED | HNLGY | OTC Markets | 4,357 |
5.8
USD
| Stock | |
| LUNG KEE (BERMUDA) HOLDINGS LIMITED | 255 | Hong Kong S.E. | 129,098 |
1.36
HKD
| Stock | |
| HON KWOK LAND INVESTMENT COMPANY, LIMITED | 160 | Hong Kong S.E. | 112,222 |
1.72
HKD
| Stock | |
| KWONG LUNG ENTERPRISE CO., LTD. | 8916 | Taipei Exchange | 311,986 |
60.1
TWD
| Stock | |
| LUNG HWA ELECTRONICS CO., LTD. | 2424 | Taiwan S.E. | 11,409 |
28.25
TWD
| Stock | |
| LUNG PIEN VACUUM INDUSTRY CO., LTD. | 5267 | Taipei Exchange | 8,665 |
37.55
TWD
| Stock | |
| LUNG MING GREEN ENERGY TECHNOLOGY ENGINEERING CO., LTD. | 3018 | Taiwan S.E. | 23,696 |
14.05
TWD
| Stock |
News (98)
Companies (190)
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), refe ...
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (neb ...
Hon Kwok Land Investment Company, Limited is a Hong Kong-based investment holding company principally engaged in property businesses. The Company operates through three segments. The Property Development segment is engaged in property development. The Pro ...
Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows: - medical systems (57.4%): equipment for opera ...
Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows: - medical systems (57.4%): equipment for opera ...
Neola Medical AB, formerly GPX Medical AB is a Sweden-based company that is involved in development of medical instruments. The Company's business concept is to commercialize the Company's medical technology product for continuous lung monitoring based on ...
Blueprint Medicines Corporation is a global precision therapy company that is inventing life-changing medicines in two areas of allergy/inflammation and oncology/hematology. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritin ...
Broncus Holding Corp is a China-based investment holding company providing innovative solutions for lung diseases. The Company's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solut ...
ImmunoGen, Inc. is a commercial-stage biotechnology company. The Company is focused on developing and commercializing of antibody- drug conjugates (ADCs) to improve outcomes for cancer patients. An ADC with the Company's technology comprises an antibody t ...
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions i ...
Insiders
Kwok Lung Hongchoy is currently the Chief Executive Officer & Executive Director at Link Real Estate Investment Trust since 2010 and at Link Asset Management Ltd.
since 2009.
He is also a Director at Link Properties Ltd.
and a Trustee at the University of Pennsylvania.
Additionally, he serves as a Member-Supervisory Board at Tracker Fund of Hong Kong and as an Adjunct Professor at the University of Hong Kong since 2020.
Mr. Hongchoy is a Member of the Hong Kong Institute of Certified Public Accountants, the New Zealand Institute of Chartered Accountants, the Royal Institution of Chartered Surveyors, the Hong Kong Securities & Investment Institute, the Hong Kong Institute of Directors, the Institute of Shopping Centre Management, the Wharton School of the University of Pennsylvania's Asia Executive Board, and Chartered Accountants Australia & New Zealand.
Formerly, Mr. Hongchoy held positions as the Managing Director-Investment Banking at NM Rothschild & Sons (Hong Kong) Ltd., the Managing Director at DBS Asia Capital Ltd., and as a Director at Link Holdings Ltd.
He also served as a Director at the Asian Public Real Estate Association Ltd., Rishon Finance Ltd., Hong Kong Cyberport Management Co. Ltd., and the Hong Kong Applied Science & Technology Research Institute.
Additionally, he was a Professor at the Hong Kong Polytechnic University and a Trustee at the Urban Land Institute.
Mr. Hongchoy was also a Governor at the Forum Mondial de L'Economie.
In terms of education, Mr. Hongchoy completed his undergraduate studies at the University of Canterbury and holds an MBA from The Wharton School of the University of Pennsylvania.
Kwok Lung Hon is currently the Chairman & Chief Executive Officer at Eterna AG Uhrenfabrik.
He is also the Chairman of Citychamp Watch & Jewellery Group Ltd., Chairman & President of Citichamp (Holdings) Ltd., Director at The Dreyfuss Group Ltd., Director at Rotary Overseas Ltd., and Executive Vice President at China Federation of Overseas Chinese Entrepreneurs.
Previously, he served as the Chairman of Citychamp Dartong Co., Ltd.
from 2001 to 2017.
Oi Lung Kwok served as an Executive Director at Tianli Holdings Group Ltd.
from 2016 to 2018.
He completed his undergraduate degree at the University of Pennsylvania and also received an undergraduate degree from The Wharton School of the University of Pennsylvania in 1998.
Kwok Lung Ho is an Independent Non-Executive Director at Hands Form Holdings Ltd.
since 2019 and a Director & Assistant Project Manager at Chi Sum Engineering Ltd.
since 2016.
He completed his undergraduate degree from Curtin University in 2008.
Yuen Lung Kwok is currently the Chief Human Resources Officer at Baozun, Inc. He previously worked as the Director of the Computer Accessories Department at Philips (China) Investment Co., Ltd.
from 2003 to 2011 and as a Non-Executive Director at Beijing Vastsmart Trading Co. Ltd.
from 2012 to 2014.
Mr. Kwok received his undergraduate degree from Fudan University in 1989.
Wai Lung Kwok served as the President, Chief Executive Officer & Director at Rentian Technology Holdings Ltd.
from 2019 to 2019.
Prior to that, he obtained an MBA from The University of York and an undergraduate degree from Sun Yat-Sen University.
No results for this search
- Stock Market
- Advanced search
- Kwok Lung Hongchoy